Quarterly revenue of $544 million, up 15% year-over-yearQuarterly Semiconductor Market revenue of $321 million, up 50% year-over-year, led by record […]
Combined company will operate as F-star Therapeutics and advance pipeline of multiple clinical-stage immuno-oncology programsCombined company expected to have at […]
IRVING, Texas, July 29, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ:XELA), a location-agnostic global business […]